Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
eNq9mFFv2jAQx9/5FFHek1CgkE6BamPthtRqjBZt2ktlkqOYBTs920D36ecQuqVTsram7iN2uLv4/v7dX4lOt6vUWQMKylnfPfKbrgMs5gllt313en3uhe7poBEtyZqUHuv5Tf+o5TpxSoTou/muPwPChP/98uIj6P8DuoOGE/HZEmL56Dklaep/JmJxSbL8GSdac5o4K5ALnvTdTMndqhMJibqKwYbjT5GRGKJgv1LeXd50yutRkAd7RlQlAC8Iu60MOkejmLFCBCaHRMItx/vq0PFNK+x1m83QKAUVExBcYQxjIhdj5GuaQFKdiaQCjJLMN8kV4DoFmSepDB4s45UwCk6WZDuBu1F10e/17lBupdf0jnrd45Nu6/i40z4xOywsHVW1ePRLBNlNu9Vtd1u9YI7BDOmKM6rlDx5fMbqmueK90rJh28YcJUktNYyK4WPpWcqDcPekMBIqspTc+0uRmR4VQaK3ATUg7L1I/gbXqJGV6jP7Jz5TaRq8sOrpHiiWKs55NeSKyRqunE9MD2LImYRtfUfNUCi3ey1SEK8X9hdn1WNgrGYpjU1pp3mkQMjpZFQPuzfixAciYIr2QPGNsoRvxOsDqNxwS9VnO4b+Z6x2wjA0vl0/tLZqptKZQp5BoMFExSG8GbE5P5Q0Wq7VoR7E+hY63bknHpMUavyTZ8gjLdAHu2ftCti7XsVGZdBPZ9emyvmqAO+vdj8rQ9Ok/6fnZrC2MQG0TmsLf7nqi6v/DGfdCdstM0ljNVkWUmbiXRBsNht/QYQniD4sX1+tNxwKpRFtz/Jb8QGFLyrQaqn0WTExX9Y807v4lFM41P3u/7932ZU5JCo4oBcFtq3BdXT2+rz+a32tlT1+xBd7aXY2lUiNBVseSc0qIx42IXRf2TlqQHyZz2nNl5haXUZB8RVo0IiC/AvQoPEbdQ0TLQ==
KECcfmbA1VxtyjQM